Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 68.74B |
| Revenue (ttm) | 141.74B |
| Net Income (ttm) | 4.58B |
| Shares Out | n/a |
| EPS (ttm) | 19.82 |
| PE Ratio | 15.01 |
| Forward PE | 11.52 |
| Dividend | 5.13 (1.27%) |
| Ex-Dividend Date | Jun 10, 2025 |
| Volume | 366 |
| Average Volume | 942 |
| Open | 407.08 |
| Previous Close | 404.08 |
| Day's Range | 406.00 - 422.54 |
| 52-Week Range | 385.00 - 516.42 |
| Beta | 0.78 |
| RSI | 47.03 |
| Earnings Date | Apr 16, 2025 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial numbers in USD Financial StatementsNews
Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Elevance Health, Inc.
NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action lawsuit in the U.S. District Court for the Southern Distri...
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward
The cannabis industry just wrapped one of the busiest earnings weeks of the quarter, with more than ten companies reporting financials—including Curaleaf, GTI, Trulieve, Verano, Cronos Group and IIPR....
Verily CEO tells staff the sale of its insurance business is a 'strategic win' as the deal closes
Elevance Health's acquisition of Verily's insurance business has closed. Verily's CEO told staff in a memo that the sale will strengthen the company's financial position.
10 Undervalued Dividend Growth Stocks: May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Elevance Health (NYSE: ELV) has outperformed the market over the past 20 years by 1.25% on an annualized basis producing an average annual return of 9.4%. Currently, Elevance Health has a market capi...
DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks
The DOJ alleges in its complaint that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers eHealth, GoHealth and SelectQuote in exchange for enrollments into the insurers' M...
US accuses health insurers, brokers of Medicare Advantage kickback scheme
BOSTON (Reuters) -The U.S. Department of Justice accused three of the nation's largest health insurers of paying hundreds of millions of dollars in kickbacks to brokers in exchange for steering patien...
Elevance Health: Carelon Growth Not Fully Appreciated
Elevance Health declares $1.71 dividend
Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ETCompany ParticipantsNathan Rich - VP, IRGail Boudreaux -...
Elevance Health, Inc. 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Elevance Health, Inc.
Elevance confirms quarterly profit beat, reaffirms 2025 forecast
Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the preliminary estimates it released last week after bellwether UnitedHealth's lowered...
Elevance Health beats top-line and bottom-line estimates; reaffirms FY25 outlook
Elevance Health Reports First Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results. “At Elevance Health, our purpose—to improve the health of humanity—drives everything we do. In the...
Elevance Health Q1 2025 Earnings Preview
A Look Ahead: Elevance Health's Earnings Forecast
Elevance Health (NYSE: ELV) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement. Analysts estimate that Elevance Hea...
Elevance Health sets Q1 earnings outlook ahead of consensus
Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results exceeds consensus. Read more here.
Health insurer Elevance sees first-quarter profit above estimates
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
How Do Investors Really Feel About Elevance Health?
Elevance Health's (NYSE: ELV) short percent of float has risen 9.01% since its last report. The company recently reported that it has 2.75 million shares sold short , which is 1.21% of all regular sh...
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
GreensKeeper Q1 2025 Portfolio Update
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...